Cancer Consortium Initiative, Research and Clinical Trial
- References:
- » SB 1379 (2025)
An independent, nonprofit entity in the Commonwealth for the purpose of coordinating, maximizing the efficiency of, and facilitating cancer clinical research and treatment efforts across the Commonwealth.
Annually
The Initiative shall include the Massey Comprehensive Cancer Center at Virginia Commonwealth University, the University of Virginia Medical Center, the Leroy T. Canoles Jr. Cancer Research Center at the Eastern Virginia Health Sciences Center at Old Dominion University, the Fralin Biomedical Research Institute at Virginia Tech Carilion, Hampton University, and three nonacademic health systems.
| Name | Representing | Appointed By | Term |
|---|
| The Honorable Peter Farrell | Senate Committee on Rules | Expires 06/30/2028 | |
| Mark T. Fleming M.D. | Having expertise in cancer clinical research and treatment | Speaker of the House | Expires 06/30/2027 |
| 1 Citizen | Having expertise in cancer clinical research and treatment or philanthropic support of cancer clinical research and treatment | Governor | Expires 06/30/2026 |
Eight representatives of health or medical institutions with expertise in cancer clinical research and treatment shall be appointed by the Commissioner as follows: one representative each from the Massey Comprehensive Cancer Center at Virginia Commonwealth University, the University of Virginia Medical Center, the Leroy T. Canoles Jr. Cancer Research Center at the Eastern Virginia Health Sciences Center at Old Dominion University, the Fralin Biomedical Research Institute at Virginia Tech Carilion, Hampton University
| Max # House: | 0 | Appointment Coincident With House Term? | YES |
| Max # Senate: | 0 | Appointment Coincident With Senate Term? | YES |
| Max # Citizens: | 3 | ||
| Max # Ex Officio: | 0 |